Table 4.
The BMD recommendations modeling hepatic endpoints for Osweiler et al. (1993) and Jennings et al. (2020).
| BMDS Recommendations and Notes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Study | FUM dataset | Endpoint | Response means | Response variability | Exponential 3 | Exponential 5 | Hill | Linear | Power | |
| Osweiler et al. (1993) | 5, 31, and 148 | AST | 70.5, 79.5, 392.3* | 2.1, 10.1, 136.7* | Unusable | Questionable | Questionable | Questionable | Questionable | |
| Did not successfully execute. | Zero degrees of freedom; saturated model | Zero degrees of freedom; saturated model | Nonconstant variance test failed (Test 3p-value < 0.05) | Zero degrees of freedom; saturated model | ||||||
| Nonconstant variance test failed (Test 3p-value < 0.05) | Nonconstant variance test failed (Test 3p-value < 0.05) | Goodness of fit p-value < 0.1 | Nonconstant variance test failed (Test 3p-value < 0.05) | |||||||
| Control stdev. fit > 1.5 | Control stdev. fit > 1.5 | Control stdev. fit > 1.5 | Control stdev. fit > 1.5 | |||||||
| Osweiler et al. (1993) | 5, 31, and 148 | GGT | 17.5, 20.5, 84.3* | 1.71, 3.67, 14.45* | Recommended: lowest AIC | Questionable | Questionable | Questionable | Questionable | |
| BMD − 18.2 | Zero degrees of freedom; saturated model | Zero degrees of freedom; saturated model | Zero degrees of freedom; saturated model | Goodness of fit p-value < 0.1 | ||||||
| BMDL − 8.2 | ||||||||||
| BMDU − 41.3 | ||||||||||
| Osweiler et al. (1993) | 5, 31, and 148 | LDH | 952.8, 970.7, 1811.1* | 55.9, 51.3, 255.8* | Recommended: lowest AIC | Questionable | Questionable | Questionable | Questionable | |
| BMD − 64.3 | Zero degrees of freedom; saturated model | Zero degrees of freedom; saturated model | Zero degrees of freedom; saturated model | Goodness of fit p-value < 0.2 | ||||||
| BMDL − 34.7 | ||||||||||
| BMDU − 134.5 | ||||||||||
| Jennings et al. (2020) | 5.0, 26.7, 40.7, | SA:SO | 0.07, 0.08, 0.2, | 0.01, 0.05, 0.12, | Questionable | Questionable | Unusable | Unusable | Unusable | |
| 67.7, and 108.8 | 0.3, and 0.8* | 0.08, and 0.45* | Control stdev. fit > 1.5 | Lowest dose/BMDL ratio > 3 | Control stdev. fit > 1.5 | Lowest dose/BMD ratio > 3 | Control stdev. fit > 1.5 | |||
| Constant variance test failed (Test 2p-value < 0.05) | Lowest dose/BMDL ratio > 10 | Constant variance test failed (Test 2p-value < 0.05) | Lowest dose/BMD ratio > 10 | Constant variance test failed (Test 2p-value < 0.05) | ||||||
| Control stdev. fit > 1.5 | BMDL does not exist | Goodness of fit p-value < 0.1 | BMDL does not exist | |||||||
| Constant variance test failed (Test 2p-value < 0.05) | Control stdev. fit > 1.5 | |||||||||
| BMD/BMDL ratio > 3 | Constant variance test failed (Test 2p-value < 0.05) | |||||||||
| BMD/BMDL ratio > 20 | BMDL does not exist |
*Reported to differ from corresponding control.